📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Opiant Pharmaceuticals

1.1 - Company Overview

Opiant Pharmaceuticals Logo

Opiant Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical treatments for drug overdose and addictions, leveraging intranasal and injectable delivery technologies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Opiant Pharmaceuticals

SafeOp Surgical Logo

SafeOp Surgical

HQ: United States Website
  • Description: Provider of a neuromonitoring device to prevent nerve damage in all types of surgical procedures, founded in 2011 and headquartered in Hunt Valley, Maryland.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SafeOp Surgical company profile →
JDS Pharmaceuticals Logo

JDS Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical solutions focused on developing prescription psychiatry products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full JDS Pharmaceuticals company profile →
Disarm Therapeutics Logo

Disarm Therapeutics

HQ: United States Website
  • Description: Provider of disease-modifying therapeutics for patients with axonal degeneration, developing drugs that prevent axon loss and treat neurological diseases including multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Disarm Therapeutics company profile →
Vapogenix Logo

Vapogenix

HQ: United States Website
  • Description: Provider of clinical-stage non-narcotic topical analgesics for localized pain, including VPX638, a Phase 2 topical for wound pain demonstrating rapid and prolonged relief without systemic side effects; a rapid-acting topical for acute procedural pain on intact skin; and a topical for localized inflammatory pain combining analgesic and anti-inflammatory effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vapogenix company profile →
NeuroPace Logo

NeuroPace

HQ: United States Website
  • Description: Provider of implantable neurostimulation devices for neurological disorders, featuring the FDA-approved RNS System for epilepsy to monitor brain activity, detect unusual patterns, and deliver responsive pulses to prevent seizures. Offers personalized neuromodulation based on patient brain activity, the nSight platform for remote data access, and clinical studies (NAUTILUS, RESPONSE, and other RNS System trials).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeuroPace company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Opiant Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Opiant Pharmaceuticals

2.2 - Growth funds investing in similar companies to Opiant Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Opiant Pharmaceuticals

4.2 - Public trading comparable groups for Opiant Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Opiant Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Opiant Pharmaceuticals

What does Opiant Pharmaceuticals do?

Opiant Pharmaceuticals is a provider of pharmaceutical treatments for drug overdose and addictions, leveraging intranasal and injectable delivery technologies.

Who are Opiant Pharmaceuticals's competitors?

Opiant Pharmaceuticals's competitors and similar companies include SafeOp Surgical, JDS Pharmaceuticals, Disarm Therapeutics, Vapogenix, and NeuroPace.

Where is Opiant Pharmaceuticals headquartered?

Opiant Pharmaceuticals is headquartered in United States.

How many employees does Opiant Pharmaceuticals have?

Opiant Pharmaceuticals has 1,000 employees 🔒.

When was Opiant Pharmaceuticals founded?

Opiant Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Opiant Pharmaceuticals in?

Opiant Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Opiant Pharmaceuticals

Who are the top strategic acquirers in Opiant Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Opiant Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Opiant Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Opiant Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Opiant Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Opiant Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Opiant Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Opiant Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Opiant Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Opiant Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Opiant Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Opiant Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Opiant Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Opiant Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Opiant Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Opiant Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Opiant Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Opiant Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Opiant Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Opiant Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Opiant Pharmaceuticals